Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Completed · Phase 3 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2, Acute Coronary Syndrome

In brief

The purpose of this study is to evaluate the cardiovascular outcomes of alogliptin, once daily (QD), compared with placebo, in addition to standard of care, in patients with type 2 diabetes mellitus and acute coronary syndrome.

Key facts

Study ID

NCT00968708

Run by

Takeda

People needed

5380

Starts

2009-09-01

Expected to finish

2013-06-01

Last updated by the study team

2014-05-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of type 2 diabetes mellitus
• Is receiving monotherapy or combination antidiabetic therapy with a glycosylated hemoglobin level between 6.5% and 11.0%, inclusive, at Screening (between 7.0 and 11.0%, inclusive, if the participant's antidiabetic regimen includes insulin)
• Diagnosis of acute coronary syndrome within 15 to 90 days prior to randomization.

You may not qualify if…

• Signs of type 1 diabetes mellitus
• Currently receiving a glucagon-like peptide-1 analogue for glycemic control of type 2 diabetes mellitus at Screening
• Received a dipeptidyl peptidase-4 inhibitor for either more than 14 days total or within the 3 months prior to Screening.

Where it is running

• Study site — Dothan, Alabama, United States
• Study site — Mobile, Alabama, United States
• Study site — Muscle Shoals, Alabama, United States
• Study site — Cottonwood, Arizona, United States
• Study site — Goodyear, Arizona, United States
• Study site — Mesa, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Little Rock, Arkansas, United States
• Study site — Malvern, Arkansas, United States
• Study site — Searcy, Arkansas, United States
• Study site — White Hall, Arkansas, United States
• Study site — Alameda, California, United States
• Study site — Aliso Viejo, California, United States
• Study site — Anaheim, California, United States
• Study site — Bell Gardens, California, United States
• Study site — Beverly Hills, California, United States
• Study site — Chula Vista, California, United States
• Study site — Corona, California, United States
• Study site — Downey, California, United States
• Study site — Escondido, California, United States
• Study site — Fullerton, California, United States
• Study site — Huntington Beach, California, United States
• Study site — Huntington Park, California, United States
• Study site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.